DuBiotech, Dubai’s dedicated biotechnology and research park, announced that Dr Brill & Partner GmbH, a German-based Institute for hygiene and microbiology has established its first Middle East operating subsidiary at the freezone.
The Dr Brill & Partner Group will provide the region with high quality hygiene and microbiology consulting, training and laboratory services to assist the Government’s drive to place public health and safety at the top of its priorities.
The announcement was made at a reception hosted on the side-lines of Arab Health 2014, and was attended by Marwan Abdulaziz, Executive Director, Dubiotech, Elke Badde, State Counsellor, Hamburg Ministry of Health and Consumer Protection, Dr Bassem El-Sayed Zayed from Ministry of Health Oman, Prof. Dr. Hans-Jörg Schmidt-Trenz, CEO of Hamburg Chamber of Commerce and Industry, including senior officials from Germany, the UAE and the region.
Commenting on the occasion, Dr Florian HH Brill, Owner and Managing Director of Dr Brill & Partner, said: “The Middle Eastern region has significant potential for developing a thriving health and life science sector. There is high demand for quality healthcare due to the prevalence of diseases specific to the region such as diabetes and cardiovascular diseases. At Dr. Brill & Partners, we focus on delivering qualitative consulting and training services with the aim of establishing the necessary healthcare standards specialized in infection prevention and control. This is of upmost importance in order to provide the rising population with a world class healthcare system. Therefore, we established an Infection Control Accreditation Program, which is designed for the Middle East Region’s healthcare facilities such as hospitals, dental and veterinary clinics.
“Tecom Investment’s DuBiotech was our first choice when searching for a regional destination in line with our expansion plans. This was due to the essential infrastructure, research facilities and various business setup services they provide to the life sciences community. The freezone has established a community of like-minded life science professionals, which aids in the success of our objectives by providing health solutions,” Dr. Brill added.
Marwan Abdulaziz, Executive Director, Tecom Investment’s DuBiotech, said: “It is very important to have well-established health and safety programmes and certification in place for patient’s safety. This is particularly important if we are to truly develop the UAE as a medical tourism hub in the region and to provide our residents with the best possible care.
“DuBiotech is dedicated to fostering and facilitating innovation, growth and collaboration within the life sciences industry. As part of this, we strive to ensure our business partners receive full support and assistance required to achieve their objectives and commercial goals to enable their success, but ultimately to ensure that this success translates to better healthcare for our nation."